Zentek (CVE:ZEN) Shares Up 21.5% – Should You Buy?

Zentek Ltd. (CVE:ZENGet Free Report) shares were up 21.5% on Friday . The stock traded as high as C$1.70 and last traded at C$1.64. Approximately 147,738 shares changed hands during trading, an increase of 343% from the average daily volume of 33,375 shares. The stock had previously closed at C$1.35.

Zentek Trading Up 21.5 %

The stock has a market cap of C$168.48 million, a price-to-earnings ratio of -15.48 and a beta of 0.77. The firm’s 50 day moving average is C$1.49 and its two-hundred day moving average is C$1.33. The company has a quick ratio of 7.59, a current ratio of 2.06 and a debt-to-equity ratio of 4.97.

About Zentek

(Get Free Report)

Zentek Ltd., together with its subsidiaries, engages in the research and development of graphene and related nanomaterials in Canada. The company develops graphene-based antimicrobial coating under the ZenGUARD brand, surgical masks, HVAC filters, personal protective equipment, rapid detection point of care diagnostics tests, and pharmaceutical products based on graphene-based compounds.

Featured Stories

Receive News & Ratings for Zentek Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Zentek and related companies with MarketBeat.com's FREE daily email newsletter.